Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Precision Medicine

Fabrice André

M.D., Ph.D.

🏢Institut Gustave Roussy🌐France

Director, Research

1
Key Papers
2
Key Contributions

👥Biography 个人简介

Fabrice André is a leader in precision breast cancer medicine who directs research at Institut Gustave Roussy. His work has advanced genomics-driven clinical trials and biomarker development for targeted therapy selection in breast cancer. André has led major European precision oncology initiatives including SAFIR trials.

Fabrice André是精准乳腺癌医学的领导者,指导古斯塔夫·鲁西研究所的研究。他的工作推进了基因组学驱动的临床试验和乳腺癌靶向治疗选择的生物标志物开发。André领导了主要的欧洲精准肿瘤学倡议,包括SAFIR试验。

Share:

🧪Research Fields 研究领域

Breast Cancer乳腺癌
Precision Medicine精准医学
Biomarkers生物标志物

🎓Key Contributions 主要贡献

SAFIR Trials

Led European precision medicine trials matching patients to targeted therapies.

Genomic Profiling

Advanced comprehensive genomic profiling for breast cancer treatment selection.

Representative Works 代表性著作

[1]

Targeting FGFR with erdafitinib in metastatic urothelial carcinoma

New England Journal of Medicine (2019)

FGFR-targeted therapy development.

📄Data Sources 数据来源

Last updated: 2026-03-05 | All information from publicly available academic sources

关注 Fabrice André 的研究动态

Follow Fabrice André's research updates

留下邮箱,当我们发布与 Fabrice André(Institut Gustave Roussy)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment